At Mercola.com, Dr. Joseph Mercola discusses the work of Dr. William LaValley, who “has created state-of-the-art databases of tens of thousands of studies covering the molecular biology of cancer and the anticancer benefits of nutritional supplements and repurposed drugs.” Mercola writes:
Editor’s Note: This article is a reprint. It was originally published May 14, 2017.
Cancer will affect half of all men and one-third of all women at some point in their lives. Having optimal metabolic flexibility can significantly reduce your chances of cancer and improve your chances of recovery, but it’s certainly not the only way to address this devastating disease.
Dr. William LaValley is one of the world’s most advanced clinical researchers and medical doctor practitioners in the field of integrative cancer treatment. He has broken new ground by creating state-of-the-art databases of tens of thousands of studies covering the molecular biology of cancer and the anticancer benefits of nutritional supplements and repurposed drugs (drugs used off-label).
LaValley Protocols — The Other Half of Cancer Treatment
LaValley, a family physician, spent a decade researching the scientific literature, ultimately developing a set of comprehensive databases that he now uses to educate other physicians about science-backed integrative treatments for cancer. He also trains physicians to treat cancer patients using evidence-based molecularly targeted treatments.
“When I was in medical school in the mid-1980s, we didn’t learn molecular biology as part of the medical school curriculum. I always felt incomplete and inadequate because I didn’t understand molecular biology,” he says. “In the beginning of 2006, I took a self-imposed sabbatical … to learn the molecular biology of cancer.
Since that time, I have developed relational databases that connect cancer cell types, molecular pathways and chemotherapy and pharmaceuticals, as well as natural products — how they interact and how they’re cross-referenced with each other.
I have spent well over 13,000 hours developing these databases that now can be used to greatly accelerate the selection of these options, because the data is organized. It’s collated. I can then go in and select specific recommendations because I know where to go look.
That information, I think, has great value for the medical community because now doctors don’t have to go and do all of that. This information is now encapsulated and in a way predigested. It has great value for the broad spectrum of cancer cell types because there’s so much data out there.”
Many Nutritional Supplements Have Anticancer Activity
LaValley’s work shows there are large amounts of data showing nutritional supplements have molecularly targeted, anticancer effects. Some readily available, commonly utilized drugs also increase anticancer activity in those with cancer, and both can be used to boost the effectiveness of conventional chemotherapy and radiation treatments.
“The challenge is that most doctors, because they are already overwhelmed … don’t have the time to dig into this information,” he says. “[There] are two other important reasons that doctors aren’t being taught about this. One is that pharmaceutical companies are restricted by law and regulation from educating about the use of their drugs except for how they’re approved …
The concept is repurposing of drugs. Doctors do it all the time, except they don’t learn about it except from other doctors. There are now doctors teaching about these commonly available drugs for anticancer activity.
In addition to that, supplement companies are forbidden from educating and marketing about the use of their products for disease treatment, specifically cancer treatment. Yet there are large amounts of data that show scientifically proven anticancer molecular effects from a whole range of natural supplements, in a whole range of cancers.”
Read more here.
If you’re willing to fight for Main Street America, click here to sign up for my free weekly email.